These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 19905900

  • 1. Hormone replacement therapy after breast cancer: attitudes of women eligible in a randomized trial.
    Wallberg B, von Schoultz E, Bolund C, Bergh J, Wilking N.
    Climacteric; 2009 Dec; 12(6):478-89. PubMed ID: 19905900
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Estrogen replacement therapy after treatment for localized breast carcinoma. Patient responses and opinions.
    Vassilopoulou-Sellin R, Klein MJ.
    Cancer; 1996 Sep 01; 78(5):1043-8. PubMed ID: 8780542
    [Abstract] [Full Text] [Related]

  • 4. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
    Holmberg L, Iversen OE, Rudenstam CM, Hammar M, Kumpulainen E, Jaskiewicz J, Jassem J, Dobaczewska D, Fjosne HE, Peralta O, Arriagada R, Holmqvist M, Maenpaa J, HABITS Study Group.
    J Natl Cancer Inst; 2008 Apr 02; 100(7):475-82. PubMed ID: 18364505
    [Abstract] [Full Text] [Related]

  • 5. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel.
    J Natl Cancer Inst Monogr; 2001 Apr 02; (30):5-15. PubMed ID: 11773285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
    Vassilopoulou-Sellin R, Theriault RL.
    J Natl Cancer Inst Monogr; 1994 Apr 02; (16):153-9. PubMed ID: 7999459
    [Abstract] [Full Text] [Related]

  • 10. Is HRT justified for symptom management in women at higher risk of developing breast cancer?
    Rippy L, Marsden J.
    Climacteric; 2006 Dec 02; 9(6):404-15. PubMed ID: 17085372
    [Abstract] [Full Text] [Related]

  • 11. Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study.
    Vassilopoulou-Sellin R, Cohen DS, Hortobagyi GN, Klein MJ, McNeese M, Singletary SE, Smith TL, Theriault RL.
    Cancer; 2002 Nov 01; 95(9):1817-26. PubMed ID: 12404273
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An informed decision? Breast cancer patients and their knowledge about treatment.
    Fagerlin A, Lakhani I, Lantz PM, Janz NK, Morrow M, Schwartz K, Deapen D, Salem B, Liu L, Katz SJ.
    Patient Educ Couns; 2006 Dec 01; 64(1-3):303-12. PubMed ID: 16860523
    [Abstract] [Full Text] [Related]

  • 14. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr 01; 12(64):65-9. PubMed ID: 12674130
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M, Koera K, Nagata H, Nakano H.
    J Obstet Gynaecol Res; 2004 Aug 01; 30(4):297-302. PubMed ID: 15238106
    [Abstract] [Full Text] [Related]

  • 17. A single mathematical model predicts physicians' recommendations and postmenopausal women's decisions to participate in a clinical trial to prevent breast cancer or coronary heart disease.
    Veit CT.
    Med Decis Making; 2004 Aug 01; 24(4):330-50. PubMed ID: 15271272
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.